4DMedical Ltd (ASX: 4DX) is a health technology SaaS business that operates in both Australia and the US. The company’s proprietary XV technology works by converting sequences of X-ray images into four-dimensional quantitative data by using patented mathematical models and algorithms.
Basically, the technology aims to improve patient experiences and outcomes by allowing doctors to make better informed decisions with earlier intervention.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.95% to 7,625.90.
4D Medical Ltd (ASX: 4DX) shares have resumed trading on the ASX today after being placed in a trading halt yesterday when the company announced a material grant and a subsequent capital raise. Here’s my take.
The 4DMedical Ltd (ASX:4DX) share price had a strong start yesterday and was up over 6% at one stage following an announcement made by the company.
Shares in 4DMedical Limited (ASX: 4DX) are up over 47% off the back of some recent positive announcements. Is it too late to buy shares?
